EU Probes German Pharma Aid Plan

The European Union is currently investigating a scheme through which German pharmaceutical companies may be granted exemptions to rebates that go to insurance companies and public sickness funds. EU governing bodies are seeking to determine whether or not this scheme complies with European regulations.
Pharma Times